Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration

被引:93
作者
Drolet, RE
Behrouz, B
Lookingland, KJ
Goudreau, JL [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA
[3] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA
关键词
Parkinson's disease; MPTP; alpha-synuclein; dopamine;
D O I
10.1016/j.neuro.2004.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The functional role of a-synuclein in the pathogenesis of Parkinson's disease (PD) is not fully understood. Systemic exposure of alpha-synuclein-deficient mice to neurotoxins provides a direct approach to evaluate how alpha-synuclein may mediate cell death in a common marine model of PD. To this end, wild-type and homozygous alpha-synuclein knock-out mice were treated with sub-chronic and prolonged, chronic exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In the sub-chronic model, wild-type and a-synuclein knock-out mice were treated for five consecutive days with MPTP (1-25 mg/kg, s.c.) or vehicle, and sacrificed 3 days,following the last injection. The prolonged, chronic model consisted of two injections of MPTP (1-20 mg/kg, s.c.) per week for 5 weeks, with co-administration of probenecid (250 mg/kg, i.p.), and animals were sacrificed 3 weeks following the last injection. Sub-chronic administration of MPTP caused a dramatic, dose-dependent decrease in striatal dopamine (DA) concentrations, while an attenuated response was observed in a-synuclein knock-out mice. Similarly, prolonged, chronic administration of MPTP produced a dose-dependent decrease in striatal DA concentrations, and a corresponding loss of striatal vesicular monoamine transporter (VMAT-2) protein in wild-type mice. However mice lacking alpha-synuclein had an attenuated loss of striatal DA concentrations, while no loss of striatal VMAT-2 protein was observed. Both sub-chronic and prolonged, chronic administration of MPTP caused an increase in the 3,4-dihydroxyphenylacetic acid (DOPAC) to DA ratio in wild-type mice, but not in mice lacking a-synuclein. Despite attenuated toxicity, elevated lactate concentrations were observed in alpha-synuclein knock-out mice following prolonged, chronic MPTP administration. The results of this study provide evidence that alpha-synuclein null mice have an attenuated response to the toxic effects of MPTP exposure, even over prolonged periods of time and that the biochemical sequela of a protracted insult to nigrostriatal DA neurons are distinct between mice with and without alpha-synuclein expression. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 39 条
  • [1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [2] PERMANENT HUMAN PARKINSONISM DUE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) - 7 CASES
    BALLARD, PA
    TETRUD, JW
    LANGSTON, JW
    [J]. NEUROLOGY, 1985, 35 (07) : 949 - 956
  • [3] RAPID ATP LOSS CAUSED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN MOUSE-BRAIN
    CHAN, P
    DELANNEY, LE
    IRWIN, I
    LANGSTON, JW
    DIMONTE, D
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) : 348 - 351
  • [4] Parkinson's disease: Mechanisms and models
    Dauer, W
    Przedborski, S
    [J]. NEURON, 2003, 39 (06) : 889 - 909
  • [5] Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
    Dauer, W
    Kholodilov, N
    Vila, M
    Trillat, AC
    Goodchild, R
    Larsen, KE
    Staal, R
    Tieu, K
    Schmitz, Y
    Yuan, CA
    Rocha, M
    Jackson-Lewis, V
    Hersch, S
    Sulzer, D
    Przedborski, S
    Burke, R
    Hen, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14524 - 14529
  • [6] Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats
    DeMaria, JE
    Lerant, AA
    Freeman, ME
    [J]. BRAIN RESEARCH, 1999, 837 (1-2) : 236 - 241
  • [7] VARIABILITY AND FUNCTIONAL RECOVERY IN THE N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MODEL OF PARKINSONISM IN MONKEYS
    EIDELBERG, E
    BROOKS, BA
    MORGAN, WW
    WALDEN, JG
    KOKEMOOR, RH
    [J]. NEUROSCIENCE, 1986, 18 (04) : 817 - 822
  • [8] Fabre E, 1999, J PHYSIOL BIOCHEM, V55, P325
  • [9] Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons
    German, DC
    Liang, CL
    Manaye, KF
    Lane, K
    Sonsalla, PK
    [J]. NEUROSCIENCE, 2000, 101 (04) : 1063 - 1069
  • [10] A dual effect of 1-methyl-4-phenylpyridinium (MPP(+))-analogs on the respiratory chain of bovine heart mitochondria
    Hasegawa, E
    Kang, D
    Sakamoto, K
    Mitsumoto, A
    Nagano, T
    Minakami, S
    Takeshige, K
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 337 (01) : 69 - 74